These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3295130)

  • 41. Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911.
    Press OW; Unger JM; Braziel RM; Maloney DG; Miller TP; Leblanc M; Fisher RI;
    J Clin Oncol; 2006 Sep; 24(25):4143-9. PubMed ID: 16896003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Case histories of extranodal non-Hodgkin's lymphomas with primary gastrointestinal appearance].
    Buda F; Buda C; La Torre F; Simon G; Binotto F; Bellomo R; Russo F; Croatto T; Duchi M; Mandoliti G
    Minerva Chir; 1993 Apr; 48(7):325-30. PubMed ID: 8327178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types).
    Bernstein JI; Coleman CN; Strickler JG; Dorfman RF; Rosenberg SA
    J Clin Oncol; 1986 Jun; 4(6):847-58. PubMed ID: 3711961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma].
    Zhang HY; Lin TY; Jiang WQ; Zhang L; Huang HQ; Xia ZJ; Sun XF; He YJ; Guan ZZ
    Ai Zheng; 2004 Dec; 23(12):1681-6. PubMed ID: 15601560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.
    Longo DL; DeVita VT; Duffey PL; Wesley MN; Ihde DC; Hubbard SM; Gilliom M; Jaffe ES; Cossman J; Fisher RI
    J Clin Oncol; 1991 Jan; 9(1):25-38. PubMed ID: 1702144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prognostic factors of follicular lymphoma treated with combination chemotherapy].
    Niitsu N; Umeda M
    Rinsho Ketsueki; 1997 Jun; 38(6):496-504. PubMed ID: 9248325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas.
    Rohatgi N; LaRocca RV; Bard V; Sethuraman G; Foon KA
    Am J Hematol; 2002 Jul; 70(3):181-5. PubMed ID: 12111762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical analysis of 82 patients with non-Hodgkin's lymphoma--mainly on the evaluation of therapeutic efficacy].
    Kakinoki Y; Maekawa I; Kawamura T; Miyake T; Kurosawa M; Okabe M; Kamiya K; Sasaki O
    Hokkaido Igaku Zasshi; 1987 Dec; 62(6):841-50. PubMed ID: 3443427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Follicular large cell lymphoma: analysis and prognostic factors in 62 patients.
    Kantarjian HM; McLaughlin P; Fuller LM; Dixon DO; Osborne BM; Cabanillas FF
    J Clin Oncol; 1984 Jul; 2(7):811-9. PubMed ID: 6376721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
    Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High rate of prolonged remissions following combined modality therapy for patients with localized low-grade lymphoma.
    Seymour JF; McLaughlin P; Fuller LM; Hagemeister FB; Hess M; Swan F; Romaguera J; Rodriguez MA; Besa P; Cox J; Cabanillas F
    Ann Oncol; 1996 Feb; 7(2):157-63. PubMed ID: 8777172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experience.
    Tezcan H; Vose JM; Bast M; Bierman PJ; Kessinger A; Armitage JO
    Leuk Lymphoma; 1999 Jul; 34(3-4):273-85. PubMed ID: 10439364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic factors and a predictive model of follicular lymphoma: a 25-year study at a single institution in Japan.
    Katsumata N; Matsuno Y; Nakayama H; Takenaka T; Kobayashi Y; Takeyama K; Narabayashi M; Fukushima T; Yokozawa T; Nakata M; Tajima K; Ikeda H; Tobinai K
    Jpn J Clin Oncol; 1996 Dec; 26(6):445-54. PubMed ID: 9001350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-grade lymphoma: clinical and prognostic studies in a series of 143 patients from a single institution.
    Lopez-Guillermo A; Montserrat E; Bosch F; Escoda L; Terol MJ; Marin P; Reverter JC; Blade J; Cervantes F; Sierra J
    Leuk Lymphoma; 1994 Sep; 15(1-2):159-65. PubMed ID: 7858494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined therapy in advanced stages (III and IV) of follicular lymphoma increases the possibility of cure: results of a large controlled clinical trial.
    Avilés A; Delgado S; Fernández R; Talavera A; Neri N; Huerta-Guzmán J
    Eur J Haematol; 2002 Mar; 68(3):144-9. PubMed ID: 12068794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Follicular lymphomas: assessment of prognostic factors in 127 patients followed for 10 years.
    Bastion Y; Berger F; Bryon PA; Felman P; Ffrench M; Coiffier B
    Ann Oncol; 1991 Feb; 2 Suppl 2():123-9. PubMed ID: 2049309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study.
    Ha CS; Kong JS; Tucker SL; McLaughlin P; Wilder RB; Hess MA; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):316-20. PubMed ID: 12957240
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alpha-interferon and corticosteroids as initial treatment in small cleaved-cell lymphoma.
    Flecknoe-Brown S
    Leuk Lymphoma; 1995 Jul; 18(3-4):353-6. PubMed ID: 8535205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Durable remissions in stage III follicular lymphoma: interpret with caution.
    Horning SJ
    J Clin Oncol; 1987 Jun; 5(6):838-9. PubMed ID: 3295128
    [No Abstract]   [Full Text] [Related]  

  • 60. Stage III nodular lymphomas. Preliminary results of a combined chemotherapy/radiotherapy program.
    Flippin T; McLaughlin P; Conrad FG; Fuller LM; Velasquez WS; Butler JJ; Shullenberger CC
    Cancer; 1983 Mar; 51(6):987-93. PubMed ID: 6821873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.